Dec 29 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS INVESTMENT COMPANY ORAVAX MEDICAL
SIGNS
COOPERATION AND PURCHASE AGREEMENT FOR INITIAL PRE-PURCHASE OF
10 MILLION DOSES OF ORAL COVID-19 VACCINE TO BE COMMERCIALIZED
IN SOUTHEAST ASIA
* MYMD PHARMACEUTICALS INC - ORAMED AND MYMD ARE CURRENTLY
EVALUATING SEVERAL OPTIONS WITH RESPECT TO THEIR INTEREST IN
ORAVAX
* MYMD PHARMACEUTICALS INC - OPTIONS INCLUDE A POTENTIAL
DISTRIBUTION OF ORAVAX SHARES TO BOTH ORAMED AND MYMD
SHAREHOLDERS
Source text for Eikon: ID:nBw9spdBya
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))